Salarius Pharmaceuticals, Inc. (SLRX)

0.7976 -0.07 (-8.11%) USD  |  NASDAQ  |  Dec 11, 12:20
More

Salarius Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for SLRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
Aptevo Therapeutics, Inc. Upgrade
Outset Medical, Inc. Upgrade
Vor Biopharma, Inc. Upgrade
Humacyte, Inc. --